Abstract:FOXN1 performs a pivotal role in the development of thymic epithelium. Homozygous FOXN1 deficiency results in T-B+NK+ SCID while FOXN1 haploinsufficiency is associated with T cell lymphopenia and nail dystrophy. We report two patients with variants of uncertain significance (VUS) in FOXN1 who presented with lymphopenia detected on newborn screening. Patient A is a 17-month-old female born to non-consanguineous parents who presented with lowT-cell receptor excision circles (TRECs). At 2 weeks old, her lymphocyte subset panel revealed low T cells, but normal B and NK cells (Table 1). Follow up at 3 months revealed uptrending T cells and significantly decreased B cells. She had no concerning clinical features or infections at that time. By 6 months, her T cells were again downtrending, but her B cells had normalized. She required antibiotics for acute otitis media, which quickly resolved. At 15 months, T cell lymphopenia persisted (Figure 2). Her infection history was reassuring, developmental milestones met and physical exam notable only for spooned nails. Patient B is a 4-month-old female also born to non-consanguineous parents presenting with low TRECs. Initial workup at 5 days revealed T cell lymphopenia, but normal B and NK cells (Table 1). At 2 months, CD4 lymphopenia persisted though CD8T cells normalized (Figure 2). She had a self-limiting upper respiratory infection, but otherwise unremarkable infection history. Development and physical exam were normal. A targeted 429-gene panel for inborn errors of immunity revealed heterozygous FOXN1 VUSs in both Patient A (c.890T > G, p.Ile297Ser) and Patient B (c.890T > C, p.Ile297Thr). Patient A's variant was not present in population databases. Patient B's variant has been observed (gnomAD frequency of 0.007%) but not present in population databases for the patient's ethnicities. Surprisingly, both are located at the same position within the Forkhead domain (Figure 1). Algorithms to predict the effect of missense changes on FOXN1 protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all predicted these variants as likely to be disruptive. Further understanding of the phenotypes associated with heterozygous FOXN1 variants of uncertain significance is crucial to guiding diagnostics, treatment, and prognosis. Table 1 Lymphocyte panel results at original presentation (Patient A: 2 weeks old, Patient B: 5 days old). Reference ranges obtained from J Allergy Clin Immunol, Volume 112, Number 5, pp 973–980, November 2003 Variant CD4+ CD45RA+ (Naïve CD4+ T Cells, cells/μL) CD4+ CD45RO+ (Memory CD4+ T cells, cells/μL) CD8+ T Cells (cells/μL) CD19+ B Cells (cells/μL) CD16+ CD56+ (NK Cells, cells/μL) Patient A c.890T>G (p.Ile297Ser) 633 100 518 423 700 Patient B c.890T>C (p.Ile297Thr) 569 126 122 610 311 Ref range (0–3 months) 1200–3700 60–900 560–1700 300–2000 170–1700 Figure 1 FOXN1 domains with locations of variants found in Patient A and B. Numbers above domains indicate amino acid number in the FOXN1 protein chain. Abbreviations: FKD, Forkhead domain; TA, transactivation domain. Figure 2: (abstract: 168) CD4+ and CD8+ trends.

FOXN1 Gene Considerations in Severe Combined Immunodeficiency Treatment in Children

Novel heterozygous FOXN1 mutation identified during newborn screening for severe combined immunodeficiency is associated with improving immune parameters

Utilization of next-generation sequencing to define the role of heterozygous FOXN1 variants in immunodeficiency

Characterization of Human FOXN1 Mutations Uncovers both Loss- and Gain-of-Function Outcomes

Abnormal Newborn Screening for Severe Combined Immunodeficiency due to CD4 T cell lymphopenia associated with Heterozygous FOXN1 Variants in the Forkhead Domain

Peripheral T Cell Development and Immunophenotyping of Twins with Heterozygous FOXN1 Mutations

Immune Reconstitution Inflammatory Syndrome After Hematopoietic Stem Cell Transplantation in a FOXN1-deficient Patient

Defining the impact of FOXN1 variants with functional assays and reaggregate thymus organ cultures reveals those with loss- and gain- of function and dominant negative consequences

Role of foxn1 in Xenopus laevis thymopoiesis.

Genetically-determined defects of T cell development

Combined immunodeficiency caused by a novel homozygous NFKB1 mutation

Why newborn screening for severe combined immunodeficiency is essential: a case report

[Advances in Newborn Screening and Immune System Reconstitution of Severe Combined Immunodeficiency].

A novel FOXF1 mutation associated with alveolar capillary dysplasia and coexisting colobomas and hemihyperplasia

Conditional Deletion of Foxg1 Delayed Myelination during Early Postnatal Brain Development

Transcriptional regulation of the thymus master regulator Foxn1

Primary immunodeficiency disease caused by MSN gene mutation in one child and literature review

Case Report: Novel Splicing Mutations in RFX5 Causing MHC Class II Deficiency

Limiting Thymic Precursor Supply Increases the Risk of Lymphoid Malignancy in Murine X-Linked Severe Combined Immunodeficiency

Combined Immunodeficiency Caused by a Novel De Novo Gain-of-Function RAC2 Mutation

Foxe1 Deletion in the Adult Mouse Is Associated With Increased Thyroidal Mast Cells and Hypothyroidism